Literature DB >> 15128479

The global epidemic of obesity: are we becoming more sympathetic?

Kevin P Davy1.   

Abstract

The relationship between obesity and sympathetic nervous system (SNS) behavior has been controversial. Existing paradigms have been opposed in their views of the directional changes in SNS activity in obesity. In addition, limitations of previous approaches to assess SNS activity have produced inconsistent findings. However, the use of state-of-the-art neurochemical and neurophysiologic techniques has improved our current understanding of this issue. There is regional heterogeneity in the SNS activation associated with obesity, with the renal and skeletal muscle circulations, but not the heart, being targets for SNS activation. Abdominal visceral fat appears to be an important depot linking obesity and skeletal muscle SNS activation. The impact of this depot on SNS activity to the kidney or other regions is unknown. Future studies are needed to address this issue as well as the mechanisms and consequences of SNS activation in visceral obesity.

Entities:  

Mesh:

Year:  2004        PMID: 15128479     DOI: 10.1007/s11906-004-0076-7

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Sympathetic-nerve activity before and after resection of an insulinoma.

Authors:  U Scherrer; R Owlya; L Trueb
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

Review 3.  Hypertension and the metabolic syndrome: closely related central origin?

Authors:  P Björntorp; G Holm; R Rosmond; B Folkow
Journal:  Blood Press       Date:  2000       Impact factor: 2.835

4.  Body fat and sympathetic nerve activity in healthy subjects.

Authors:  U Scherrer; D Randin; L Tappy; P Vollenweider; E Jéquier; P Nicod
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

5.  Sympathetic neural activation in visceral obesity.

Authors:  Guy E Alvarez; Stacy D Beske; Tasha P Ballard; Kevin P Davy
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

6.  Adrenergic and reflex abnormalities in obesity-related hypertension.

Authors:  G Grassi; G Seravalle; R Dell'Oro; C Turri; G B Bolla; G Mancia
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

7.  Trends in waist circumference among U.S. adults.

Authors:  Earl S Ford; Ali H Mokdad; Wayne H Giles
Journal:  Obes Res       Date:  2003-10

8.  Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat.

Authors:  M Spraul; E A Anderson; C Bogardus; E Ravussin
Journal:  Diabetes       Date:  1994-02       Impact factor: 9.461

9.  Whole body, adipose tissue, and forearm norepinephrine kinetics in lean and obese women.

Authors:  S W Coppack; J F Horowitz; D S Paramore; P E Cryer; H D Royal; S Klein
Journal:  Am J Physiol       Date:  1998-11

10.  Subcutaneous obesity is not associated with sympathetic neural activation.

Authors:  Guy E Alvarez; Tasha P Ballard; Stacy D Beske; Kevin P Davy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-26       Impact factor: 4.733

View more
  4 in total

1.  Cardiovascular Consequences of Obesity and Targets for Treatment.

Authors:  Bettina Mittendorfer; Linda R Peterson
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 2.  Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism.

Authors:  Linda R Peterson
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

3.  Obesity and cardiovascular risk in children and adolescents.

Authors:  Manu Raj
Journal:  Indian J Endocrinol Metab       Date:  2012-01

4.  Regulation of alternative splicing in obesity-induced hypertension.

Authors:  Zodwa Dlamini; Rodney Hull; Tshepiso J Makhafola; Mzwandile Mbele
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-28       Impact factor: 3.168

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.